NGMedical to Present MOVE®-C at Eurospine and NASS 2026

NONNWEILER, GERMANY, October 5, 2026 /CourierPR/ -- NGMedical GmbH, a leading innovator in spinal motion preservation technology, is set to present its unique product portfolio at two major spine congresses in 2026, marking a significant step in the company's international expansion.

At the Eurospine congress in Gothenburg and the North American Spine Society (NASS) event in San Antonio, NGMedical will showcase its flagship product, the MOVE®-C cervical artificial disc. This innovative device is the only articulating-viscoelastic cer-vical artificial disc on the market, offering a new level of cervical motion preservation.

The MOVE®-C prosthesis has been in clinical use for over 6.5 years, with a proven track record of safety and functionality. The excellent results from this extensive clinical experience support NGMedical's further international expansion plans. The company has added several new countries to its international presence in 2026, with more than five new market launches planned within the next five months.

NGMedical GmbH, an owner-managed company specializing in the development of innovative spinal implants, continues to advance the field of spine surgery through scientific research, intensive mechanical tests, and clinical control. The company's commitment to innovation is evident in its portfolio, which includes not only the MOVE®-C but also other state-of-the-art fusion products.

With its strong presence in Europe and North America, NGMedical is well-positioned to continue its growth in the global market. The upcoming congresses will provide a platform for the company to further establish its reputation and expand its network of partners and distributors.